Arcturus Therapeutics Ltd. Proceeds from Issuance Initial Public Offering
Arcturus Therapeutics Ltd. reported Proceeds from Issuance Initial Public Offering of $0 for the 12-month period ending 2016-12-31, per its 20-F filed 2017-04-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2017-04-28
| Period end | Proceeds from Issuance Initial Public Offering 12 month | Proceeds from Issuance Initial Public Offering 71 month |
|---|---|---|
| 2016-12-31 | $0.00 20-F · filed 2017-04-28 | |
| 2015-12-31 | $66.46M 20-F · filed 2017-04-28 | |
| 2014-12-31 | $0.00 20-F · filed 2017-04-28 | |
| 2013-12-31 | $57.25M 20-F · filed 2016-03-04 | $57.25M 20-F · filed 2014-03-28 |
| 2012-12-31 | $0.00 20-F · filed 2015-02-27 | |
| 2011-12-31 | $0.00 20-F · filed 2014-03-28 |